Equity Gap were delighted to congratulate their portfolio company, EnteroBiotix, on two counts. Winning the ‘Innovation – Pharma Services & Drug Discovery Award’ at the Scottish Life Science Event in Glasgow and they announced the positive topline data from their TrIuMPH Phase 2a study which evaluated their investigational full-spectrum microbi9ome product in IBS.
Congratulations to EnteroBiotix
